Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma

Author： Avilés Agustín   Neri Natividad   Nambo M.   Huerta-Guzman Judith   Cleto Sergio  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.23, Iss.2, 2006-06, pp. : 295-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgery Plus Chemotherapy or Chemotherapy Alone for Primary Intermediate- and High-grade Gastric Non-Hodgkin's Lymphoma: The Royal Marsden Hospital Experience

By Popescu R.A.   Wotherspoon A.C.   Cunningham D.   Norman A.   Prendiville J.   Hill M.E.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 928-934

Elsevier

Access to resources Recommend Favorite

CHOP-based Chemotherapy is as Effective as Alternating PEEC/CHOP Chemotherapy in a Randomised Trial in High-grade Non-Hodgkin's Lymphoma

By Scotland and Newcastle Lymphoma Group   Cameron D.A.   White J.M.   Proctor S.J.   Prescott R.J.   Leonard R.C.F.   Angus B.   Cook M.K.   Dawes P.J.D.K.   Dawson A.A.   Evans R.G.B.   Galloway M.J.   Harris A.L.   Heppleston A.   Horne C.H.W.   Krajewski A.S.   Lennard A.L.   Lessells A.M.   Lucraft H.H.   MacGillivray J.B.   Mackie M.J.   Parker A.C.   Roberts J.T.   Taylor P.R.A.   Thompson W.D.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1195-1201

Elsevier

Access to resources Recommend Favorite

Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor After Combined Chemotherapy in High-grade Non-Hodgkin's Lymphoma--a Randomised Pilot Study

By Bergmann L.   Karakas T.   Knuth A.   Lautenschlager G.   Mitrou P.S.   Hoelzer D.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2164-2168

Elsevier

Access to resources Recommend Favorite

Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup

By Hauben E.I.   Weeden S.   Pringle J.   Van Marck E.A.   Hogendoorn P.C.W.   on behalf of the European Osteosarcoma Intergroup  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1218-1225

Elsevier

Access to resources Recommend Favorite

A comment and update on ''Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup''

By Bacci G.   Ferrari S.   Bertoni F.   Longhi A.   Bacchini P.   Giacomini S.   Forni C.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 548-549

Elsevier

Access to resources Recommend Favorite